BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang K, Jiang Y, Wang B, Li T, Shang D, Zhang X. Mesenchymal Stem Cell Therapy: A Potential Treatment Targeting Pathological Manifestations of Traumatic Brain Injury. Oxid Med Cell Longev 2022;2022:4645021. [PMID: 35757508 DOI: 10.1155/2022/4645021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Khan NA, Asim M, El-menyar A, Biswas KH, Rizoli S, Al-thani H. The evolving role of extracellular vesicles (exosomes) as biomarkers in traumatic brain injury: Clinical perspectives and therapeutic implications. Front Aging Neurosci 2022;14:933434. [DOI: 10.3389/fnagi.2022.933434] [Reference Citation Analysis]
2 Liu X, Zhang G, Wei P, Hao L, Zhong L, Zhong K, Liu C, Liu P, Feng Q, Wang S, Zhang J, Tian R, Zhou L. 3D-printed collagen/silk fibroin/secretome derived from bFGF-pretreated HUCMSCs scaffolds enhanced therapeutic ability in canines traumatic brain injury model. Front Bioeng Biotechnol 2022;10:995099. [DOI: 10.3389/fbioe.2022.995099] [Reference Citation Analysis]